Osteoporosis Market Set to Expand Significantly During the Forecast Period (2025-2034) Due to Rising Aging Population and Novel Therapeutics | DelveInsight
The osteoporosis market is expanding steadily, driven largely by aging populations and rising awareness of fracture risk and bone health. Advances in diagnostics and novel therapies, including EB613 (EnteraBio), AGA2118 (Angitia Biopharmaceuticals), RT-102 (Rani Therapeutics), and others, are widening treatment options and boosting market value. DelveInsight's Osteoporosis Market Insightsreport includes a comprehensive understanding of current […]